Ectodomain shedding and ADAMs in development

Development (Cambridge)

Volumn 139, Issue 20, 2012, Pages 3693-3709

  Weber, Silvio ^a   Saftig, Paul ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

ADAM; Cell fate determination; Differentiation; Ectodomain shedding; Notch

Indexed keywords

ADAM PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; NOTCH RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CATALYSIS; CELL DIFFERENTIATION; CELL FATE; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; INVERTEBRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE;

ADAM PROTEINS; ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC DEVELOPMENT; HUMANS; INVERTEBRATES; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; VERTEBRATES;

INVERTEBRATA; VERTEBRATA;

EID: 84866487100     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.076398     Document Type: Review

References (233)

1. Adrain, C., Zettl, M., Christova, Y., Taylor, N. and Freeman, M. (2012). Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225-228.
2. Albrecht, S., Wang, S., Holz, A., Bergter, A. and Paululat, A. (2006). The ADAM metalloprotease Kuzbanian is crucial for proper heart formation in Drosophila melanogaster. Mech. Dev. 123, 372-387.
3. Alfandari, D., Wolfsberg, T. G., White, J. M. and DeSimone, D. W. (1997). ADAM 13, a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. Dev. Biol. 182, 314-330.
4. Alfandari, D., McCusker, C. and Cousin, H. (2009). ADAM function in embryogenesis. Semin. Cell Dev. Biol. 20, 153-163.
5. Alfandari, D., Cousin, H. and Marsden, M. (2010). Mechanism of Xenopus cranial neural crest cell migration. Cell Adh. Migr. 4, 553-560.
6. Altmeppen, H. C., Prox, J., Puig, B., Kluth, M. A., Bernreuther, C., Thurm, D., Jorissen, E., Petrowitz, B., Bartsch, U., De Strooper, B. et al. (2011). Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol. Neurodegener. 6, 36.
7. Andersson, E. R., Sandberg, R. and Lendahl, U. (2011). Notch signaling: simplicity in design, versatility in function. Development 138, 3593-3612.
8. Angerer, L., Hussain, S., Wei, Z. and Livingston, B. T. (2006). Sea urchin metalloproteases: a genomic survey of the BMP-1/tolloid-like, MMP and ADAM families. Dev. Biol. 300, 267-281.
9. Asai, M., Hattori, C., Szabo, B., Sasagawa, N., Maruyama, K., Tanuma, S. and Ishiura, S. (2003). Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem. Biophys. Res. Commun. 301, 231-235.
10. Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H. et al. (2002). Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8, 35-40.
11. Baertling, F., Kokozidou, M., Pufe, T., Clarner, T., Windoffer, R., Wruck, C. J., Brandenburg, L. O., Beyer, C. and Kipp, M. (2010). ADAM12 is expressed by astrocytes during experimental demyelination. Brain Res. 1326, 1-14.
12. Bartsch, J. W., Wildeboer, D., Koller, G., Naus, S., Rittger, A., Moss, M. L., Minai, Y. and Jockusch, H. (2010). Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J. Neurosci. 30, 12210-12218.
13. Bech-Serra, J. J., Santiago-Josefat, B., Esselens, C., Saftig, P., Baselga, J., Arribas, J. and Canals, F. (2006). Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol. Cell. Biol. 26, 5086-5095.
14. Becherer, J. D. and Blobel, C. P. (2003). Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs). Curr. Top. Dev. Biol. 54, 101-123.
15. Bender, M., Hofmann, S., Stegner, D., Chalaris, A., Bosl, M., Braun, A., Scheller, J., Rose-John, S. and Nieswandt, B. (2010). Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 116, 3347-3355.
16. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S. et al. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733.
17. Blakey, J. D., Sayers, I., Ring, S. M., Strachan, D. P. and Hall, I. P. (2009). Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort. Thorax 64, 381-387.
18. Blaydon, D. C., Biancheri, P., Di, W.-L., Plagnol, V., Cabral, R. M., Brooke, M. A., van Heel, D. A., Ruschendorf, F., Toynbee, M., Walne, A. et al. (2011). Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 365, 1502-1508.
19. Blaydon, D. C., Etheridge, S. L., Risk, J. M., Hennies, H. C., Gay, L. J., Carroll, R., Plagnol, V., McRonald, F. E., Stevens, H. P., Spurr, N. K. et al. (2012). RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am. J. Hum. Genet. 90, 340-346.
20. Blobel, C. P. (2005). ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43.
21. Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, P. and White, J. M. (1992). A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356, 248-252.
22. Bloch, L., Sineshchekova, O., Reichenbach, D., Reiss, K., Saftig, P., Kuro-o, M. and Kaether, C. (2009). Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett. 583, 3221-3224.
23. Bode, W., Gomis-Rüth, F. X. and Stöckler, W. (1993). Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 331,134-140.
24. Bohm, B., Hess, S., Krause, K., Schirner, A., Ewald, W., Aigner, T. and Burkhardt, H. (2010). ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up-regulation of the X-linked inhibitor of apoptosis. Arthritis Rheum. 62, 1372-1382.
25. Bohm, B. B., Aigner, T., Roy, B., Brodie, T. A., Blobel, C. P. and Burkhardt, H. (2005). Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Arthritis Rheum. 52, 1100-1109.
26. Bozkulak, E. C. and Weinmaster, G. (2009). Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 29, 5679-5695.
27. Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, A., Roux, P., Black, R. A. and Israel, A. (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207-216.
28. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P. and Black, R. A. (1998). Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767.
29. Cao, Y., Kang, Q., Zhao, Z. and Zolkiewska, A. (2002). Intracellular processing of metalloprotease disintegrin ADAM12. J. Biol. Chem. 277, 26403-26411.
30. Chaimowitz, N. S., Martin, R. K., Cichy, J., Gibb, D. R., Patil, P., Kang, D. J., Farnsworth, J., Butcher, E. C., McCright, B. and Conrad, D. H. (2011). A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture. J. Immunol. 187, 5114-5122.
31. Chalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S. and Scheller, J. (2007). Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110, 1748-1755.
32. Chalaris, A., Adam, N., Sina, C., Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., Hartmann, D., Cichy, J., Gavrilova, O., Schreiber, S. et al. (2010). Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J. Exp. Med. 207, 1617-1624.
33. Chen, C., Huang, X. and Sheppard, D. (2006). ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol. Cell. Biol. 26, 6950-6956.
34. Chesneau, V., Becherer, J. D., Zheng, Y., Erdjument-Bromage, H., Tempst, P. and Blobel, C. P. (2003). Catalytic properties of ADAM19. J. Biol. Chem. 278, 22331-22340.
35. Cho, C., Bunch, D. O., Faure, J. E., Goulding, E. H., Eddy, E. M., Primakoff, P. and Myles, D. G. (1998). Fertilization defects in sperm from mice lacking fertilin beta. Science 281, 1857-1859.
36. Contin, C., Pitard, V., Itai, T., Nagata, S., Moreau, J. F. and Dechanet-Merville, J. (2003). Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J. Biol. Chem. 278, 32801-32809.
37. Cousin, H., Abbruzzese, G., Kerdavid, E., Gaultier, A. and Alfandari, D. (2011). Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration. Dev. Cell 20, 256-263.
38. De Strooper, B. and Annaert, W. (2010). Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu. Rev. Cell Dev. Biol. 26, 235-260.
39. Diaz-Rodriguez, E., Montero, J. C., Esparis-Ogando, A., Yuste, L. and Pandiella, A. (2002). Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735, a potential role in regulated shedding. Mol. Biol. Cell 13, 2031-2044.
40. Duffy, M. J., McKiernan, E., O'Donovan, N. and McGowan, P. M. (2009a). Role of ADAMs in cancer formation and progression. Clin. Cancer Res. 15, 1140-1144.
41. Duffy, M. J., McKiernan, E., O'Donovan, N. and McGowan, P. M. (2009b). The role of ADAMs in disease pathophysiology. Clin. Chim. Acta 403, 31-36.
42. Dyczynska, E., Sun, D., Yi, H., Sehara-Fujisawa, A., Blobel, C. P. and Zolkiewska, A. (2007). Proteolytic processing of delta-like 1 by ADAM proteases. J. Biol. Chem. 282, 436-444.
43. Edwards, D. R., Handsley, M. M. and Pennington, C. J. (2008). The ADAM metalloproteinases. Mol. Aspects Med. 29, 258-289.
44. Eichenauer, D. A., Simhadri, V. L., von Strandmann, E. P., Ludwig, A., Matthews, V., Reiners, K. S., von Tresckow, B., Saftig, P., Rose-John, S., Engert, A. et al. (2007). ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Cancer Res. 67, 332-338.
45. Endres, K. and Fahrenholz, F. (2010). Upregulation of the alpha-secretase ADAM10 - risk or reason for hope? FEBS J. 277, 1585-1596.
46. Fabre-Lafay, S., Garrido-Urbani, S., Reymond, N., Goncalves, A., Dubreuil, P. and Lopez, M. (2005). Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J. Biol. Chem. 280, 19543-19550.
47. Fambrough, D., Pan, D., Rubin, G. M. and Goodman, C. S. (1996). The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila. Proc. Natl. Acad. Sci. USA 93, 13233-13238.
48. Fluhrer, R. and Haass, C. (2007). Signal peptide peptidases and gamma-secretase: cousins of the same protease family? Neurodegener. Dis. 4, 112-116.
49. Fluhrer, R., Steiner, H. and Haass, C. (2009). Intramembrane proteolysis by signal peptide peptidases: a comparative discussion of GXGD-type aspartyl proteases. J. Biol. Chem. 284, 13975-13979.
50. Fourie, A. M., Coles, F., Moreno, V. and Karlsson, L. (2003). Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 278, 30469-30477.
51. Franzke, C. W., Tasanen, K., Schacke, H., Zhou, Z., Tryggvason, K., Mauch, C., Zigrino, P., Sunnarborg, S., Lee, D. C., Fahrenholz, F. et al. (2002). Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J. 21, 5026-5035.
52. Franzke, C. W., Cobzaru, C., Triantafyllopoulou, A., Loffek, S., Horiuchi, K., Threadgill, D. W., Kurz, T., van Rooijen, N., Bruckner-Tuderman, L. and Blobel, C. P. (2012). Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J. Exp. Med. 209, 1105-1119.
53. Garton, K. J., Gough, P. J., Philalay, J., Wille, P. T., Blobel, C. P., Whitehead, R. H., Dempsey, P. J. and Raines, E. W. (2003). Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J. Biol. Chem. 278, 37459-37464.
54. Gelling, R. W., Yan, W., Al-Noori, S., Pardini, A., Morton, G. J., Ogimoto, K., Schwartz, M. W. and Dempsey, P. J. (2008). Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology 149, 6053-6064.
55. Gibb, D. R., El Shikh, M., Kang, D. J., Rowe, W. J., El Sayed, R., Cichy, J., Yagita, H., Tew, J. G., Dempsey, P. J., Crawford, H. C. et al. (2010). ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J. Exp. Med. 207, 623-635.
56. Gibb, D. R., Saleem, S. J., Kang, D. J., Subler, M. A. and Conrad, D. H. (2011). ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch. J. Immunol. 186, 4244-4252.
57. Glomski, K., Monette, S., Manova, K., De Strooper, B., Saftig, P. and Blobel, C. P. (2011). Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood 118, 1163-1174.
58. Gomez-Gaviro, M., Dominguez-Luis, M., Canchado, J., Calafat, J., Janssen, H., Lara-Pezzi, E., Fourie, A., Tugores, A., Valenzuela-Fernandez, A., Mollinedo, F. et al. (2007). Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J. Immunol. 178, 8053-8063.
59. Gomis-Rüth, F. X. (2003). Structural aspects of the metzincin clan of metalloendopeptidases. Mol. Biotechnol. 4, 157-202.
60. Gossens, K., Naus, S., Hollander, G. A. and Ziltener, H. J. (2010). Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity. PLoS ONE 5, e12766.
61. Guaiquil, V., Swendeman, S., Yoshida, T., Chavala, S., Campochiaro, P. A. and Blobel, C. P. (2009). ADAM9 is involved in pathological retinal neovascularization. Mol. Cell. Biol. 29, 2694-2703.
62. Guaiquil, V. H., Swendeman, S., Zhou, W., Guaiquil, P., Weskamp, G., Bartsch, J. W. and Blobel, C. P. (2010). ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice. J. Mol. Med. (Berl.) 88, 497-505.
63. Gunn, T. M., Azarani, A., Kim, P. H., Hyman, R. W., Davis, R. W. and Barsh, G. S. (2002). Identification and preliminary characterization of mouse Adam33. BMC Genet. 3, 2.
64. Guo, L. T., Shelton, G. D., Wewer, U. M. and Engvall, E. (2005). ADAM12 overexpression does not improve outcome in mice with laminin alpha2-deficient muscular dystrophy. Neuromuscul. Disord. 15, 786-789.
65. Gutwein, P., Mechtersheimer, S., Riedle, S., Stoeck, A., Gast, D., Joumaa, S., Zentgraf, H., Fogel, M. and Altevogt, D. P. (2003). ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J. 17, 292-294.
66. Hansen, H. P., Dietrich, S., Kisseleva, T., Mokros, T., Mentlein, R., Lange, H. H., Murphy, G. and Lemke, H. (2000). CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J. Immunol. 165, 6703-6709.
67. Harsha, A., Stojadinovic, O., Brem, H., Sehara-Fujisawa, A., Wewer, U., Loomis, C. A., Blobel, C. P. and Tomic-Canic, M. (2008). ADAM12: a potential target for the treatment of chronic wounds. J. Mol. Med. (Berl.) 86, 961-969.
68. Hart, S., Fischer, O. M., Prenzel, N., Zwick-Wallasch, E., Schneider, M., Hennighausen, L. and Ullrich, A. (2005). GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol. Chem. 386, 845-855.
69. Hartmann, D., de Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Lubke, T., Lena Illert, A., von Figura, K. et al. (2002). The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 11, 2615-2624.
70. Hassemer, E. L., Le Gall, S. M., Liegel, R., McNally, M., Chang, B., Zeiss, C. J., Dubielzig, R. D., Horiuchi, K., Kimura, T., Okada, Y. et al. (2010). The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17. Genetics 185, 245-255.
71. Hattori, M., Osterfield, M. and Flanagan, J. G. (2000). Regulated cleavage of a contact-mediated axon repellent. Science 289, 1360-1365.
72. He, Z. Y., Brakebusch, C., Fassler, R., Kreidberg, J. A., Primakoff, P. and Myles, D. G. (2003). None of the integrins known to be present on the mouse egg or to be ADAM receptors are essential for sperm-egg binding and fusion. Dev. Biol. 254, 226-237.
73. Hennet, T., Hagen, F. K., Tabak, L. A. and Marth, J. D. (1995). T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92, 12070-12074.
74. Higuchi, Y., Yasui, A., Matsuura, K. and Yamamoto, S. (2002). CD156 transgenic mice. Different responses between inflammatory types. Pathobiology 70, 47-54.
75. Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M. and Tanaka, S. (2006). Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand. J. Biol. Chem. 281, 36846-36855.
76. Horiuchi, K., Weskamp, G., Lum, L., Hammes, H. P., Cai, H., Brodie, T. A., Ludwig, T., Chiusaroli, R., Baron, R., Preissner, K. T. et al. (2003). Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 23, 5614-5624.
77. Horiuchi, K., Zhou, H. M., Kelly, K., Manova, K. and Blobel, C. P. (2005). Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev. Biol. 283, 459-471.
78. Horiuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y. and Blobel, C. P. (2007). Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 179, 2686-2689.
79. Howard, L., Maciewicz, R. A. and Blobel, C. P. (2000). Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem. J. 348, 21-27.
80. Howard, L., Zheng, Y., Horrocks, M., Maciewicz, R. A. and Blobel, C. (2001). Catalytic activity of ADAM28. FEBS Lett. 498, 82-86.
81. Huang, X., Huang, P., Robinson, M. K., Stern, M. J. and Jin, Y. (2003). UNC-71, a disintegrin and metalloprotease (ADAM) protein, regulates motor axon guidance and sex myoblast migration in C. elegans. Development 130, 3147-3161.
82. Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V. et al. (2003). The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102, 1186-1195.
83. Huovila, A. P., Turner, A. J., Pelto-Huikko, M., Karkkainen, I. and Ortiz, R. M. (2005). Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30, 413-422.
84. Huxley-Jones, J., Clarke, T. K., Beck, C., Toubaris, G., Robertson, D. L. and Boot-Handford, R. P. (2007). The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio. BMC Evol. Biol. 7, 63.
85. Iba, K., Albrechtsen, R., Gilpin, B., Frohlich, C., Loechel, F., Zolkiewska, A., Ishiguro, K., Kojima, T., Liu, W., Langford, J. K. et al. (2000). The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J. Cell Biol. 149, 1143-1156.
86. Iida, A., Sakaguchi, K., Sato, K., Sakurai, H., Nishimura, D., Iwaki, A., Takeuchi, M., Kobayashi, M., Misaki, K., Yonemura, S. et al. (2010). Metalloprotease-dependent onset of blood circulation in zebrafish. Curr. Biol. 20, 1110-1116.
87. Inoshima, I., Inoshima, N., Wilke, G. A., Powers, M. E., Frank, K. M., Wang, Y. and Bubeck Wardenburg, J. (2011). A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17, 1310-1314.
88. Inoshima, N., Wang, Y. and Wardenburg, J. B. (2012). Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 132, 1513-1516.
89. Ishizuka, H., Garcia-Palacios, V., Lu, G., Subler, M. A., Zhang, H., Boykin, C. S., Choi, S. J., Zhao, L., Patrene, K., Galson, D. L. et al. (2011). ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J. Bone Miner. Res. 26, 169-181.
90. Iwamoto, R. and Mekada, E. (2006). ErbB and HB-EGF signaling in heart development and function. Cell Struct. Funct. 31, 1-14.
91. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S. et al. (1998). A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260-7272.
92. Jackson, L. F., Qiu, T. H., Sunnarborg, S. W., Chang, A., Zhang, C., Patterson, C. and Lee, D. C. (2003). Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22, 2704-2716.
93. Janes, P. W., Saha, N., Barton, W. A., Kolev, M. V., Wimmer-Kleikamp, S. H., Nievergall, E., Blobel, C. P., Himanen, J. P., Lackmann, M. and Nikolov, D. B. (2005). Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123, 291-304.
94. Janes, P. W., Wimmer-Kleikamp, S. H., Frangakis, A. S., Treble, K., Griesshaber, B., Sabet, O., Grabenbauer, M., Ting, A. Y., Saftig, P., Bastiaens, P. I. et al. (2009). Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol. 7, e1000215.
95. Jarriault, S. and Greenwald, I. (2005). Evidence for functional redundancy between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE. Dev. Biol. 287, 1-10.
96. Jie, Z., Hu, Z., Bai, C. and Jin, M. (2011). ADAM33 gene polymorphisms associate with asthma susceptibility and severity in East China han population. J. Asthma 48, 979-985.
97. Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., Snellinx, A., Craessaerts, K., Thathiah, A., Tesseur, I. et al. (2010). The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 30, 4833-4844.
98. Kang, T., Zhao, Y. G., Pei, D., Sucic, J. F. and Sang, Q. X. (2002). 'Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J. Biol. Chem. 277, 25583-25591.
99. Kawaguchi, N., Xu, X., Tajima, R., Kronqvist, P., Sundberg, C., Loechel, F., Albrechtsen, R. and Wewer, U. M. (2002). ADAM 12 protease induces adipogenesis in transgenic mice. Am. J. Pathol. 160, 1895-1903.
100. Kelly, K., Hutchinson, G., Nebenius-Oosthuizen, D., Smith, A. J., Bartsch, J. W., Horiuchi, K., Rittger, A., Manova, K., Docherty, A. J. and Blobel, C. P. (2005). Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev. Dyn. 232, 221-231.
101. Kenny, P. A. and Bissell, M. J. (2007). Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest. 117, 337-345.
102. Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J., Williams, S. C., Richardson, J. A. and Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
103. Koike, H., Tomioka, S., Sorimachi, H., Saido, T. C., Maruyama, K., Okuyama, A., Fujisawa-Sehara, A., Ohno, S., Suzuki, K. and Ishiura, S. (1999). Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343, 371-375.
104. Komatsu, K., Wakatsuki, S., Yamada, S., Yamamura, K., Miyazaki, J. and Sehara-Fujisawa, A. (2007). Meltrin beta expressed in cardiac neural crest cells is required for ventricular septum formation of the heart. Dev. Biol. 303, 82-92.
105. Kopan, R. and Ilagan, M. X. (2009). The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233.
106. Kronqvist, P., Kawaguchi, N., Albrechtsen, R., Xu, X., Schroder, H. D., Moghadaszadeh, B., Nielsen, F. C., Frohlich, C., Engvall, E. and Wewer, U. M. (2002). ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. Am. J. Pathol. 161, 1535-1540.
107. Kuhn, P. H., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Rossner, S. and Lichtenthaler, S. F. (2010). ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032.
108. Kurisaki, T., Masuda, A., Sudo, K., Sakagami, J., Higashiyama, S., Matsuda, Y., Nagabukuro, A., Tsuji, A., Nabeshima, Y., Asano, M. et al. (2003). Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol. Cell. Biol. 23, 55-61.
109. Kurohara, K., Komatsu, K., Kurisaki, T., Masuda, A., Irie, N., Asano, M., Sudo, K., Nabeshima, Y., Iwakura, Y. and Sehara-Fujisawa, A. (2004). Essential roles of Meltrin beta (ADAM19) in heart development. Dev. Biol. 267, 14-28.
110. Kveiborg, M., Frohlich, C., Albrechtsen, R., Tischler, V., Dietrich, N., Holck, P. , Kronqvist, P. , Rank, F., Mercurio, A. M. and Wewer, U. M. (2005). A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res. 65, 4754-4761.
111. Kveiborg, M., Albrechtsen, R., Rudkjaer, L., Wen, G., Damgaard-Pedersen, K. and Wewer, U. M. (2006). ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation J. Bone Miner. Res. 21, 1288-1296.
112. La Marca, R., Cerri, F. , Horiuchi, K., Bachi, A., Feltri, M. L., Wrabetz, L., Blobel, C. P. , Quattrini, A., Salzer, J. L. and Taveggia, C. (2011). TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865.
113. Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P. , Parkin, E. T., Smith, A. I., Hooper, N. M. and Turner, A. J. (2005). Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113-30119.
114. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C. and Fahrenholz, F. (1999). Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96, 3922-39217.
115. Li, N., Wang, Y., Forbes, K., Vignali, K. M., Heale, B. S., Saftig, P. , Hartmann, D., Black, R. A., Rossi, J. J., Blobel, C. P. et al. (2007). Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J. 26, 494-504.
116. Liu, P. C., Liu, X., Li, Y., Covington, M., Wynn, R., Huber, R., Hillman, M., Yang, G., Ellis, D., Marando, C. et al. (2006). Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol. Ther. 5, 657-664.
117. Lo Sardo, V., Zuccato, C., Gaudenzi, G., Vitali, B., Ramos, C., Tartari, M., Myre, M. A., Walker, J. A., Pistocchi, A., Conti, L. et al. (2012). An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin. Nat. Neurosci. 15, 713-721.
118. Loechel, F., Fox, J. W., Murphy, G., Albrechtsen, R. and Wewer, U. M. (2000). ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem. Biophys. Res. Commun. 278, 511-515.
119. Long, C., Wang, Y., Herrera, A. H., Horiuchi, K. and Walcheck, B. (2010). In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. J. Leukoc. Biol. 87, 1097-1101.
120. Lorenzen, I., Trad, A. and Grotzinger, J. (2011). Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain. Biochem. Biophys. Res. Commun. 415, 330-336.
121. Lorenzen, I., Lokau, J., Dusterhoft, S., Trad, A., Garbers, C., Scheller, J., Rose-John, S. and Grotzinger, J. (2012). The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II. FEBS Lett. 586, 1093-1100.
122. Lum, L., Reid, M. S. and Blobel, C. P. (1998). Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J. Biol. Chem. 273, 26236-26247.
123. Manilay, J. O., Anderson, A. C., Kang, C. and Robey, E. A. (2005). Impairment of thymocyte development by dominant-negative Kuzbanian (ADAM-10) is rescued by the Notch ligand, delta-1. J. Immunol. 174, 6732-6741.
124. Marcello, E., Gardoni, F. , Di Luca, M. and Perez-Otano, I. (2010). An arginine stretch limits ADAM10 exit from the endoplasmic reticulum. J. Biol. Chem. 285, 10376-10384.
125. Maretzky, T., Reiss, K., Ludwig, A., Buchholz, J., Scholz, F. , Proksch, E., de Strooper, B., Hartmann, D. and Saftig, P. (2005a). ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. USA 102, 9182-9187.
126. Maretzky, T., Schulte, M., Ludwig, A., Rose-John, S., Blobel, C., Hartmann, D., Altevogt, P. , Saftig, P. and Reiss, K. (2005b). L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell. Biol. 25, 9040-9053.
127. Martin, J., Eynstone, L. V. , Davies, M., Williams, J. D. and Steadman, R. (2002). The role of ADAM 15 in glomerular mesangial cell migration. J. Biol. Chem. 277, 33683-36689.
128. Martin, L., Fluhrer, R., Reiss, K., Kremmer, E., Saftig, P. and Haass, C. (2008). Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J. Biol. Chem. 283, 1644-1652.
129. Martin, L., Fluhrer, R. and Haass, C. (2009). Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis. J. Biol. Chem. 284, 5662-5670.
130. Marzia, M., Guaiquil, V. , Horne, W. C., Blobel, C. P. , Baron, R. and Chiusaroli, R. (2011). Lack of ADAM15 in mice is associated with increased osteoblast function and bone mass. Biol. Chem. 392, 877-885.
131. Masaki, M., Kurisaki, T., Shirakawa, K. and Sehara-Fujisawa, A. (2005). Role of meltrin {alpha} (ADAM12) in obesity induced by high-fat diet. Endocrinology 146, 1752-1763.
132. Maskos, K., Fernandez-Catalan, C., Huber, R., Bourenkov, G. P. , Bartunik, H., Ellestad, G. A., Reddy, P. , Wolfson, M. F. , Rauch, C. T. , Castner, B. J. et al. (1998). Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl. Acad. Sci. USA 95, 3408-3412.
133. Mathews, J. A., Ford, J., Norton, S., Kang, D., Dellinger, A., Gibb, D. R., Ford, A. Q., Massay, H., Kepley, C. L., Scherle, P. et al. (2011). A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy 66, 1193-1200.
134. Matthews, V. , Schuster, B., Schutze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T. , Saftig, P. , Hartmann, D., Kallen, K. J. et al. (2003). Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J. Biol. Chem. 278, 38829-38839.
135. Mauch, C., Zamek, J., Abety, A. N., Grimberg, G., Fox, J. W. and Zigrino, P. (2010). Accelerated wound repair in ADAM-9 knockout animals. J. Invest. Dermatol. 130, 2120-2130.
136. Mazzocca, A., Coppari, R., De Franco, R., Cho, J. Y., Libermann, T. A., Pinzani, M. and Toker, A. (2005). A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 65, 4728-4738.
137. McCusker, C., Cousin, H., Neuner, R. and Alfandari, D. (2009). Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration. Mol. Biol. Cell 20, 78-89.
138. McIlwain, D. R., Lang, P. A., Maretzky, T., Hamada, K., Ohishi, K., Maney, S. K., Berger, T., Murthy, A., Duncan, G., Xu, H. C. et al. (2012). iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335, 229-232.
139. Meng, J. F. , McFall, C. and Rosenwasser, L. J. (2007). Polymorphism R62W results in resistance of CD23 to enzymatic cleavage in cultured cells. Genes Immun. 8, 215-223.
140. Meyer, H., Panz, M., Albrecht, S., Drechsler, M., Wang, S., Husken, M., Lehmacher, C. and Paululat, A. (2011). Drosophila metalloproteases in development and differentiation: the role of ADAM proteins and their relatives. Eur. J. Cell Biol. 90, 770-778.
141. Milla, M. E., Leesnitzer, M. A., Moss, M. L., Clay, W. C., Carter, H. L., Miller, A. B., Su, J. L., Lambert, M. H., Willard, D. H., Sheeley, D. M. et al. (1999). Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J. Biol. Chem. 274, 30563-30570.
142. Millichip, M. I., Dallas, D. J., Wu, E., Dale, S. and McKie, N. (1998). The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Commun. 245, 594-598.
143. Mitchell, K. J., Pinson, K. I., Kelly, O. G., Brennan, J., Zupicich, J., Scherz, P. , Leighton, P. A., Goodrich, L. V. , Lu, X., Avery, B. J. et al. (2001). Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 28, 241-249.
144. Miyake, Y., Tanaka, K. and Arakawa, M. (2012). ADAM33 polymorphisms, smoking and asthma in Japanese women: the Kyushu Okinawa Maternal and Child Health Study. Int. J. Tuberc. Lung Dis. 16, 974-979.
145. Mochizuki, S., Shimoda, M., Shiomi, T., Fujii, Y. and Okada, Y. (2004). ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem. Biophys. Res. Commun. 315, 79-84.
146. Mochizuki, S., Tanaka, R., Shimoda, M., Onuma, J., Fujii, Y. , Jinno, H. and Okada, Y. (2010). Connective tissue growth factor is a substrate of ADAM28. Biochem. Biophys. Res. Commun. 402, 651-657.
147. Mohan, S., Thompson, G. R., Amaar, Y. G., Hathaway, G., Tschesche, H. and Baylink, D. J. (2002). ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41, 15394-15403.
148. Mori, S., Tanaka, M., Nanba, D., Nishiwaki, E., Ishiguro, H., Higashiyama, S. and Matsuura, N. (2003). PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 278, 46029-46034.
149. Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D. et al. (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736.
150. Moss, M. L., Stoeck, A., Yan, W. and Dempsey, P. J. (2008). ADAM10 as a target for anti-cancer therapy. Curr. Pharm. Biotechnol. 9, 2-8.
151. Murthy, A., Defamie, V. , Smookler, D. S., Di Grappa, M. A., Horiuchi, K., Federici, M., Sibilia, M., Blobel, C. P. and Khokha, R. (2010). Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J. Clin. Invest. 120, 2731-2744.
152. Murthy, A., Shao, Y. W., Narala, S. R., Molyneux, S. D., Zuniga-Pflucker, J. C. and Khokha, R. (2012). Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 36, 105-119.
153. Nagano, O., Murakami, D., Hartmann, D., De Strooper, B., Saftig, P. , Iwatsubo, T., Nakajima, M., Shinohara, M. and Saya, H. (2004). Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J. Cell Biol. 165, 893-902.
154. Najy, A. J., Day, K. C. and Day, M. L. (2008). The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J. Biol. Chem. 283, 18393-18401.
155. Nakamura, T., Abe, H., Hirata, A. and Shimoda, C. (2004). ADAM family protein Mde10 is essential for development of spore envelopes in the fission yeast Schizosaccharomyces pombe. Eukaryot. Cell 3, 27-39.
156. Naus, S., Reipschlager, S., Wildeboer, D., Lichtenthaler, S. F. , Mitterreiter, S., Guan, Z., Moss, M. L. and Bartsch, J. W. (2006). Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol. Chem. 387, 337-346.
157. Naus, S., Blanchet, M. R., Gossens, K., Zaph, C., Bartsch, J. W., McNagny, K. M. and Ziltener, H. J. (2010). The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma. Am. J. Respir. Crit. Care Med. 181, 1318-1328.
158. Neuner, R., Cousin, H., McCusker, C., Coyne, M. and Alfandari, D. (2009). Xenopus ADAM19 is involved in neural, neural crest and muscle development. Mech. Dev. 126, 240-255.
159. Nishimura, H., Kim, E., Nakanishi, T. and Baba, T. (2004). Possible function of the ADAM1a/ADAM2 Fertilin complex in the appearance of ADAM3 on the sperm surface. J. Biol. Chem. 279, 34957-34962.
160. Orth, P. , Reichert, P. , Wang, W., Prosise, W. W., Yarosh-Tomaine, T. , Hammond, G., Ingram, R. N., Xiao, L., Mirza, U. A., Zou, J. et al. (2004). Crystal structure of the catalytic domain of human ADAM33. J. Mol. Biol. 335, 129-137.
161. Overall, C. M. and Blobel, C. P. (2007). In search of partners: linking extracellular proteases to substrates. Nat. Rev. Mol. Cell Biol. 8, 245-257.
162. Pan, D. and Rubin, G. M. (1997). Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271-280.
163. Parry, D. A., Toomes, C., Bida, L., Danciger, M., Towns, K. V. , McKibbin, M., Jacobson, S. G., Logan, C. V., Ali, M., Bond, J. et al. (2009). Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice. Am. J. Hum. Genet. 84, 683-691.
164. Paulissen, G., Rocks, N., Gueders, M. M., Bedoret, D., Crahay, C., Quesada-Calvo, F. , Hacha, J., Bekaert, S., Desmet, C., Foidart, J. M. et al. (2011). ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation. Eur. J. Immunol. 41, 380-391.
165. Peduto, L., Reuter, V. E., Shaffer, D. R., Scher, H. I. and Blobel, C. P. (2005). Critical function for ADAM9 in mouse prostate cancer. Cancer Res. 65, 9312-9319.
166. Peschon, J. J., Slack, J. L., Reddy, P. , Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N. et al. (1998). An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284.
167. Pierfelice, T., Alberi, L. and Gaiano, N. (2011). Notch in the vertebrate nervous system: an old dog with new tricks. Neuron 69, 840-855.
168. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M. et al. (2004). A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456-1464.
169. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C. and Ullrich, A. (1999). EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888.
170. Prox, J., Willenbrock, M., Weber, S., Lehmann, T., Schmidt-Arras, D., Schwanbeck, R., Saftig, P. and Schwake, M. (2012). Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10. Cell. Mol. Life Sci. 69, 2919-2932.
171. Puente, X. S. and Lopez-Otin, C. (2004). A genomic analysis of rat proteases and protease inhibitors. Genome Res. 14, 609-622.
172. Raby, B. A., Silverman, E. K., Kwiatkowski, D. J., Lange, C., Lazarus, R. and Weiss, S. T. (2004). ADAM33 polymorphisms and phenotype associations in childhood asthma. J. Allergy Clin. Immunol. 113, 1071-1078.
173. Reddy, P. , Slack, J. L., Davis, R., Cerretti, D. P. , Kozlosky, C. J., Blanton, R. A., Shows, D., Peschon, J. J. and Black, R. A. (2000). Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275, 14608-14614.
174. Reiss, K. and Saftig, P. (2009). The 'a disintegrin and metalloprotease' (ADAM) family of sheddases: physiological and cellular functions. Semin. Cell Dev. Biol. 20, 126-137.
175. Reiss, K., Maretzky, T., Ludwig, A., Tousseyn, T. , de Strooper, B., Hartmann, D. and Saftig, P. (2005). ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J. 24, 742-752.
176. Reiss, K., Maretzky, T., Haas, I. G., Schulte, M., Ludwig, A., Frank, M. and Saftig, P. (2006). Regulated ADAM10-dependent ectodomain shedding of gamma-protocadherin C3 modulates cell-cell adhesion. J. Biol. Chem. 281, 21735-21744.
177. Roca, C. and Adams, R. H. (2007). Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 21, 2511-2524.
178. Roghani, M., Becherer, J. D., Moss, M. L., Atherton, R. E., Erdjument-Bromage, H., Arribas, J., Blackburn, R. K., Weskamp, G., Tempst, P. and Blobel, C. P. (1999). Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 274, 3531-3540.
179. Rooke, J., Pan, D., Xu, T. and Rubin, G. M. (1996). KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273, 1227-1231.
180. Roy, R., Wewer, U. M., Zurakowski, D., Pories, S. E. and Moses, M. A. (2004). ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J. Biol. Chem. 279, 51323-51330.
181. Saftig, P. and Reiss, K. (2011). The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90, 527-535.
182. Sagane, K., Hayakawa, K., Kai, J., Hirohashi, T., Takahashi, E., Miyamoto, N., Ino, M., Oki, T., Yamazaki, K. and Nagasu, T. (2005). Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci. 6, 33.
183. Sahin, U. and Blobel, C. P. (2007). Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Lett. 581, 41-44.
184. Sahin, U., Weskamp, G., Kelly, K., Zhou, H. M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P. and Blobel, C. P. (2004). Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769-779.
185. Schafer, B., Gschwind, A. and Ullrich, A. (2004). Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23, 991-999.
186. Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J., Lambert, M., Skelton, L., Jockusch, H. et al. (2002). The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J. Biol. Chem. 277, 48210-48219.
187. Schlondorff, J., Becherer, J. D. and Blobel, C. P. (2000). Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem. J. 347, 131-138.
188. Schmitt, U., Hiemke, C., Fahrenholz, F. and Schroeder, A. (2006). Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice. Behav. Brain Res. 175, 278-284.
189. Schulte, M., Reiss, K., Lettau, M., Maretzky, T., Ludwig, A., Hartmann, D., de Strooper, B., Janssen, O. and Saftig, P. (2007). ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 14, 1040-1049.
190. Schulz, B., Pruessmeyer, J., Maretzky, T., Ludwig, A., Blobel, C. P. , Saftig, P. and Reiss, K. (2008). ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ. Res. 102, 1192-1201.
191. Seals, D. F. and Courtneidge, S. A. (2003). The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17, 7-30.
192. Shamsadin, R., Adham, I. M., Nayernia, K., Heinlein, U. A., Oberwinkler, H. and Engel, W. (1999). Male mice deficient for germ-cell cyritestin are infertile. Biol. Reprod. 61, 1445-1451.
193. Shi, W., Chen, H., Sun, J., Buckley, S., Zhao, J., Anderson, K. D., Williams, R. G. and Warburton, D. (2003). TACE is required for fetal murine cardiac development and modeling. Dev. Biol. 261, 371-380.
194. Shirakabe, K., Wakatsuki, S., Kurisaki, T. and Fujisawa-Sehara, A. (2001). Roles of Meltrin beta /ADAM19 in the processing of neuregulin. J. Biol. Chem. 276, 9352-9358.
195. Six, E., Ndiaye, D., Laabi, Y. , Brou, C., Gupta-Rossi, N., Israel, A. and Logeat, F. (2003). The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc. Natl. Acad. Sci. USA 100, 7638-7643.
196. Smith, K. M., Gaultier, A., Cousin, H., Alfandari, D., White, J. M. and DeSimone, D. W. (2002). The cysteine-rich domain regulates ADAM protease function in vivo. J. Cell Biol. 159, 893-902.
197. Solanas, G., Cortina, C., Sevillano, M. and Batlle, E. (2011). Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat. Cell Biol. 13, 1100-1107.
198. Sulis, M. L., Saftig, P. and Ferrando, A. A. (2011). Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL. Leukemia 25, 1564-1569.
199. Sundberg, C., Thodeti, C. K., Kveiborg, M., Larsson, C., Parker, P. , Albrechtsen, R. and Wewer, U. M. (2004). Regulation of ADAM12 cell-surface expression by protein kinase C epsilon. J. Biol. Chem. 279, 51601-51611.
200. Takahashi, E., Sagane, K., Nagasu, T. and Kuromitsu, J. (2006a). Altered nociceptive response in ADAM11-deficient mice. Brain Res. 1097, 39-42.
201. Takahashi, E., Sagane, K., Oki, T., Yamazaki, K., Nagasu, T. and Kuromitsu, J. (2006b). Deficits in spatial learning and motor coordination in ADAM11-deficient mice. BMC Neurosci. 7, 19.
202. Takeda, S., Igarashi, T., Mori, H. and Araki, S. (2006). Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J. 25, 2388-2396.
203. Tian, L., Wu, X., Chi, C., Han, M., Xu, T. and Zhuang, Y. (2008). ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int. Immunol. 20, 1181-1187.
204. Tousseyn, T., Thathiah, A., Jorissen, E., Raemaekers, T., Konietzko, U., Reiss, K., Maes, E., Snellinx, A., Serneels, L., Nyabi, O. et al. (2009). ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J. Biol. Chem. 284, 11738-11747.
205. Tsakadze, N. L., Sithu, S. D., Sen, U., English, W. R., Murphy, G. and D'Souza, S. E. (2006). Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J. Biol. Chem. 281, 3157-3164.
206. Van Eerdewegh, P., Little, R. D., Dupuis, J., Del Mastro, R. G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K. et al. (2002). Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430.
207. Vincent, B., Paitel, E., Saftig, P. , Frobert, Y., Hartmann, D., De Strooper, B., Grassi, J., Lopez-Perez, E. and Checler, F. (2001). The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276, 37743-37746.
208. Wakatsuki, S., Yumoto, N., Komatsu, K., Araki, T. and Sehara-Fujisawa, A. (2009). Roles of meltrin-beta/ADAM19 in progression of Schwann cell differentiation and myelination during sciatic nerve regeneration. J. Biol. Chem. 284, 2957-2966.
209. Waldhauer, I., Goehlsdorf, D., Gieseke, F. , Weinschenk, T. , Wittenbrink, M., Ludwig, A., Stevanovic, S., Rammensee, H. G. and Steinle, A. (2008). Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68, 6368-6376.
210. Wang, Y., Zhang, A. C., Ni, Z., Herrera, A. and Walcheck, B. (2010). ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. J. Immunol. 184, 4447-4454.
211. Watt, F. M., Estrach, S. and Ambler, C. A. (2008). Epidermal Notch signalling: differentiation, cancer and adhesion. Curr. Opin. Cell Biol. 20, 171-179.
212. Weber, S., Niessen, M. T., Prox, J., Lullmann-Rauch, R., Schmitz, A., Schwanbeck, R., Blobel, C. P. , Jorissen, E., de Strooper, B., Niessen, C. M. et al. (2011). The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 138, 495-505.
213. Wei, S., Xu, G., Bridges, L. C., Williams, P. , White, J. M. and DeSimone, D. W. (2010). ADAM13 induces cranial neural crest by cleaving class B Ephrins and regulating Wnt signaling. Dev. Cell 19, 345-352.
214. Wei, S., Xu, G., Bridges, L. C., Williams, P. , Nakayama, T., Shah, A., Grainger, R. M., White, J. M. and DeSimone, D. W. (2012). Roles of ADAM13-regulated Wnt activity in early Xenopus eye development. Dev. Biol. 363, 147-154.
215. Wen, C., Metzstein, M. M. and Greenwald, I. (1997). SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. Development 124, 4759-4767.
216. Weskamp, G., Cai, H., Brodie, T. A., Higashyama, S., Manova, K., Ludwig, T. and Blobel, C. P. (2002). Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 22, 1537-1544.
217. Weskamp, G., Ford, J. W., Sturgill, J., Martin, S., Docherty, A. J., Swendeman, S., Broadway, N., Hartmann, D., Saftig, P. , Umland, S. et al. (2006). ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 7, 1293-1298.
218. Weskamp, G., Mendelson, K., Swendeman, S., Le Gall, S., Ma, Y., Lyman, S., Hinoki, A., Eguchi, S., Guaiquil, V. , Horiuchi, K. et al. (2010). Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ. Res. 106, 932-940.
219. White, J. M. (2003). ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 15, 598-606.
220. Wild-Bode, C., Fellerer, K., Kugler, J., Haass, C. and Capell, A. (2006). A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration. J. Biol. Chem. 281, 23824-23829.
221. Wolfsberg, T. G., Bazan, J. F., Blobel, C. P. , Myles, D. G., Primakoff, P. and White, J. M. (1993).The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications. Proc. Natl. Acad. Sci. USA 90, 10783-10787.
222. Xie, B., Shen, J., Dong, A., Swaim, M., Hackett, S. F. , Wyder, L., Worpenberg, S., Barbieri, S. and Campochiaro, P. A. (2008). An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization. FASEB J. 22, 2775-2783.
223. Xu, H., Zhu, J., Smith, S., Foldi, J., Zhao, B., Chung, A. Y., Outtz, H., Kitajewski, J., Shi, C., Weber, S. et al. (2012). Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 13, 642-650.
224. Yagami-Hiromasa, T. , Sato, T., Kurisaki, T., Kamijo, K., Nabeshima, Y. and Fujisawa-Sehara, A. (1995). A metalloprotease-disintegrin participating in myoblast fusion. Nature 377, 652-656.
225. Yoda, M., Kimura, T., Tohmonda, T., Uchikawa, S., Koba, T. , Takito, J., Morioka, H., Matsumoto, M., Link, D. C., Chiba, K. et al. (2011). Dual functions of cell-autonomous and non-cell-autonomous ADAM10 activity in granulopoiesis. Blood 118, 6939-6942.
226. Yumoto, N., Wakatsuki, S., Kurisaki, T. , Hara, Y. , Osumi, N., Frisen, J. and Sehara-Fujisawa, A. (2008). Meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PLoS ONE 3, e3322.
227. Zack, M. D., Melton, M. A., Stock, J. L., Storer, C. E., Barve, R. A., Minnerly, J. C., Weiss, D. J., Stejskal, J. A., Tortorella, M. D., Turk, J. R. et al. (2009). Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8). Clin. Exp. Immunol. 158, 246-256.
228. Zhao, J., Chen, H., Wang, Y. L. and Warburton, D. (2001). Abrogation of tumor necrosis factor-alpha converting enzyme inhibits embryonic lung morphogenesis in culture. Int. J. Dev. Biol. 45, 623-631.
229. Zheng, Y., Saftig, P. , Hartmann, D. and Blobel, C. (2004). Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J. Biol. Chem. 279, 42898-42906.
230. Zhong, J. L., Poghosyan, Z., Pennington, C. J., Scott, X., Handsley, M. M., Warn, A., Gavrilovic, J., Honert, K., Kruger, A., Span, P. N. et al. (2008). Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Mol. Cancer Res. 6, 383-394.
231. Zhou, H. M., Weskamp, G., Chesneau, V., Sahin, U., Vortkamp, A., Horiuchi, K., Chiusaroli, R., Hahn, R., Wilkes, D., Fisher, P. et al. (2004). Essential role for ADAM19 in cardiovascular morphogenesis. Mol. Cell. Biol. 24, 96-104.
232. Zolkiewska, A. (1999). Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain. Exp. Cell. Res. 252, 423-431.
233. Zou, J., Zhang, R., Zhu, F. , Liu, J., Madison, V. and Umland, S. P. (2005). ADAM33 enzyme properties and substrate specificity. Biochemistry 44, 4247-4256.